Oral fluid drug testing has proven to be a simple and effective resource for clinicians dedicated to providing exceptional and safe patient care. The information provided allows valuable insight into patient’s medication usage, inconsistencies and possible drug interactions. AFTS Labs’ cutting edge oral fluid drug monitoring program enables clinicians to treat patients with a high degree of confidence.
AFTS Labs employs Fully Automated Enzyme-Linked Immunosorbent Assay (ELISA) screening techniques and provides quantitative drug levels utilizing the “Platinum Standard” UPLC/MS/MS. Screening Results will be reported within 24 hours and quantitative results within 72 hours.